Management of Hashimoto’s Thyroiditis (HT)

  • Management of euthyroid patients with positive thyroid antibody titers:
    • Can typically be monitored without the institution of thyroid hormone replacement therapy:
      • However, there are some data that pregnant patients with positive thyroid antibody titers may have improved pregnancy outcomes and reduced complications with the institution of LT4 replacement therapy
  • In non-pregnant patients with hypothyroidism:
    • There are standard recommendations for treatment and monitoring:
      • This usually consist of LT4 therapy and TSH and FT4 monitoring every 6 weeks with adjustments in LT4 dosing until the TSH is within the goal range (typically 1 to 3 uIU/mL) although a higher target range is considered
        acceptable in the elderly patients

Leave a comment